Zinforo is indicated in adults and children from age of 2 months for the treatment of the following infections :• Complicated skin and soft tissue infections (cSSTI)• Community-acquired pneumonia (CAP) Consideration should be given to official guidance on the appropriate use of antibacterial agents..